Quarterly Transactions Made in Seelos Therapeutics, Inc. (SEEL)
This table provides information about the institutional ownership of Seelos Therapeutics, Inc. (SEEL). The information is specifically focused on institutions that hold shares of SEELOS THERAPEUTICS, INC..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q4 2020 | 404,562 | 599,975 | 1,004,537 | 193,497 | 650,791 | 844,288 | 160,249 | |
| Q1 2021 | 1,595,839 | 14,504,608 | 16,100,447 | 635,484 | 903,860 | 1,539,344 | 14,561,103 | |
| Q2 2021 | 9,182,637 | 20,777,943 | 29,960,580 | 5,406,139 | 3,593,029 | 8,999,168 | 20,961,412 | |
| Q3 2021 | 5,363,784 | 2,265,907 | 7,629,691 | 4,086,793 | 2,178,145 | 6,264,938 | 1,364,753 | |
| Q4 2021 | 2,324,936 | 1,946,510 | 4,271,446 | 2,203,921 | 1,210,314 | 3,414,235 | 857,211 | |
| Q1 2022 | 5,914,949 | 1,924,052 | 7,839,001 | 5,594,721 | 3,402,014 | 8,996,735 | -1,157,734 | |
| Q2 2022 | 3,853,367 | 2,435,024 | 6,288,391 | 12,310,074 | 1,830,429 | 14,140,503 | -7,852,112 | |
| Q3 2022 | 1,236,289 | 264,076 | 1,500,365 | 5,277,658 | 7,869 | 5,285,527 | -3,785,162 | |
| Q4 2022 | 109,209 | 1,232,558 | 1,341,767 | 3,694,675 | 0 | 3,694,675 | -2,352,908 | |
| Q1 2023 | 477,231 | 1,171,385 | 1,648,616 | 1,435,195 | 0 | 1,435,195 | 213,421 | |
| Q2 2023 | 1,127,750 | 836,106 | 1,963,856 | 852,681 | 0 | 852,681 | 1,111,175 | |
| Q3 2023 | 5,614,095 | 12,600,198 | 18,214,293 | 1,247,763 | 0 | 1,247,763 | 16,966,530 | |
| Q4 2023 | 0 | 83 | 83 | 0 | 1,000 | 1,000 | -917 | |